© Copyright 2024 – CytoJournal.
Published by Scientific Scholar, USA
ISSN (Print): 0974-5963
ISSN (Online): 1742-6413
About the Journal
Aims and Scope
CytoJournal is an open-access, peer-reviewed biomedical journal dedicated to publishing research on cellular pathology and molecular pathology. It aims to elucidate the roles and implications of cells or cell-related molecules, signaling, and electrophysiological behaviors in mediating diseases and in disease diagnosis and treatment. These publications cover research on pre-translational experiments and novel findings and insights in clinical practice.
Audience
CytoJournal aims to establish an authoritative platform for scientists, healthcare professionals, and pathologists to facilitate academic exchange and promote the rapid spread and application of pertinent knowledge.Review Process
CytoJournal has a highly rigorous double anonymized peer-review process that makes sure that manuscripts are scientifically accurate, relevant, novel and important. Authors disclose all conflicts of interest, affiliations and financial disclosures such that the published content is not biased.
In-house submissions that contain the work of any editorial board member, are not allowed to be reviewed by that editorial board member and all decisions regarding this manuscript are made by an independent editor. In addition, these manuscripts are reviewed by two external reviewers. This is also disclosed in the published manuscript under the section of Conflict of Interest.
Editorial Team
The editorial board comprises a panel of experts from various disciplines of Diagnostic pathology and other medical allied sciences to provide their expertise and guidance in maintaining the clarity of content and focus of the purpose for the journal with a focus on diagnostic Cytopathology including molecular pathology. To access more information about the Editorial Team, visit https://cytojournal.com/editorial-board/.
Other Facts About the Journal
This is a peer reviewed journal published Continuous, follows a double-blind review process. Its open access model ensures worldwide visibility and boosts authors’ prominence in medical research.
Abstracting and Indexing Information
The journal is indexed with or included in the following:PubMed Central, Scimago Journal Ranking, SCOPUS, Science Citation Index Expanded
- Impact Factor® as reported in the 2023 Journal Citation Reports® (Clarivate Analytics 2024): 2.5
- Scopus CiteScore 2023 (as per SJR 2024): 2.2
The journal is registered with the following abstracting partners:EBSCO, Google Scholar, ProQuest, CrossRef, ReadCube, EMBASE/ Excerpta Medica, Portico
Journal Ethics
The CytoJournal is committed to meeting and upholding the standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit our Ethical Guidelines section.
Plagiarism Policy
The journal uses plagiarism check software (iThenticate) on the Editor’s and Reviewer’s panel in the manuscript management system which is used to check and control Plagiarism for each article. Any manuscript, that is found to have plagiarism is rejected.Open Access Publication and Creative Commons Licensing
CytoJournal is an open-access journal, and manuscripts published are distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License (CC-BY-NC-SA 4.0), which allows others to remix, transform, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Ahead of Print Policy
This is a continuous publication.Advertisements
While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place (https://scientificscholar.com/adv-policies/) to ensure the integrity of the journal and its content are not biased or influenced by the advertisement.
“Pop-up” and “Banner” advertisement appears at a fixed location on the page and does not interfere with the reading/display of the manuscript in any form. (https://cytojournal.com/advertise/)
All advertisements are approved in consultation with Editor-In-Chief/the Editorial Board.
Advertisers submit their advertisements without prior information of the journal content to be published.
All advertisements are approved in consultation with the Editor-In-Chief or the Editorial Board. Advertisements and commercially sponsored publications are independent of editorial decisions. Editorial decisions are not influenced by current or potential sponsors and advertisers, nor by marketing considerations.
Subscription Information
This is a continuous publication and published manuscripts in the journal can be read and downloaded by readers all over the world without any charges or fees.
The journal is published in E-Journal format and the journal is also available in print on demand. The journal offers a Print-on-Demand subscription – https://scientificscholar.com/buy-subscriptions.
Publisher
Scientific Scholar LLC (scientificscholar.com) is a well-respected medical publisher that fully supports open access publishing models, Subscription and Society based journal models through its own in-house peer-review management system – EditorialAssist (journalmanagement.org). The head office of Scientific Scholar is in Rochester, NY, USA and has a subsidiary arm in India.
The mission of the Scientific Scholar is “Share, Learn and Improve”.
